₹1420.0
-2.07% today
· 30d +3.27%
as of 2026-09-04
Price · Daily Candles
“Concord Biotech Navigates Volatile Markets as FIIs Nibble Amidst Profit Margin Contraction”
Concord Biotech, with a market cap of ₹11914.0 Cr, reported 13.74% YoY revenue growth but a 16.17% YoY net profit decline in Q4 2025. This comes alongside a 5.65 percentage point drop in operating profit margin to 37.87%. Over the last six months, the stock has seen a significant price correction of -21.58%.
BULL CASE
+Annual revenue witnessed a healthy 13.85% YoY growth to ₹1200.0 Cr in FY2025, with a 3-year CAGR of 17.68%.
+Net profit recorded a substantial 20.62% YoY increase to ₹372.0 Cr in FY2025, with a 3-year CAGR of 28.55%.
+The company maintains a high ROCE of 28.0%, exceeding many of its peers in the Biotechnology sector.
+FII shareholding increased slightly by 0.22 percentage points QoQ to 7.8% in Q4 2026.
BEAR CASE
−Q4 2025 net profit declined by 16.17% YoY despite a 13.74% revenue increase.
−Operating profit margin (OPM) contracted by 5.65 percentage points YoY to 37.87% in Q4 2025.
−Stock price has seen a considerable correction, down 21.58% in the last 6 months and 24.91% over the last year.
−The stock is trading 47.17% below its 52-week high of ₹2150.4.
⟳ What Changed
₹ Latest Earnings · Q ending 2026-03-31
REVENUE
₹326 Cr
-24.15% YoY
NET PROFIT
₹88 Cr
-36.98% YoY
OPM
39.21%
-6.27pp YoY
EPS
₹8.46
PE 38.25
Intrinsic value · DCF: N/A — ML model predicts severe Δ FCF compression (h1=-41.0%, h2=-42.9%, h3=-34.1% of mktcap), driving projected FCF negative by year 3 despite healthy current FCF. Treating as forecast outlier rather than reporting a misleading ₹0 valuation. Use the Strategy Fit and ML sections instead.
◇ Sector Position
Concord Biotech's TTM PE of 38.25 and ROCE of 28.0% position it favorably against peers like BIOCON (PE 183.16, ROCE 10.11%) but lower than BLUEJET (PE 34.97, ROCE 36.5%).
PEERPEROCE %
CONCORDBIO38.2528.0
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒
54
SCORE / 100
Overall
6-axis composite of the sections below.
Performance
UNDERPERFORMER
20
Valuation
FAIR
40
Growth
DECLINING
24
Profitability
HIGH
92
Technicals
NEUTRAL
67
Risk
LOW
80
Key Stats
TTM PE
38.25
P/B
6.57
52W HIGH
₹1801.9
OFF HIGH
-21.19%
DIV YIELD
0.95%
MKT CAP
₹14892 Cr
◉ Active Signals
MACDNeutral-19.1597
RSI(14)Neutral44.72
Street Consensus
5 analysts₹1319.0
mean target
Low ₹1170.0Now ₹1420.0High ₹1400.0
⧉ Strategy Fit 🔒